Back to Type 2 Diabetes

NCT06473831

NCT06473831
Active, Not Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

Who might be able to join this trial:

  • You are between 18 and 65 years old at the time of signing the consent form
  • Your Body Mass Index (BMI) is between 30 and 50 (a measure of weight relative to height)
  • You have Type 2 diabetes (with a blood sugar marker called HbA1c of 6.5% or higher) and had weight-loss stomach surgery (sleeve gastrectomy) at least 12 months ago; OR you have Type 2 diabetes and have never had that surgery and are not planning to have it at the same time as this study procedure; OR you have regained weight after having sleeve gastrectomy surgery at least 12 months ago
  • You agree not to have any other weight-loss or body-reshaping surgery during the study period
  • You have been fully informed about the study, agree to follow all its requirements including check-up visits and any required medications, and have signed a consent form
  • You have been assessed by a medical team as a suitable candidate for a specific bowel-connection procedure (duodenal ileal anastomosis) and have completed all the standard pre-surgery evaluations required by the trial site

Who may not be able to join:

  • You have Type 1 diabetes
  • You currently use insulin injections
  • Your Type 2 diabetes is not well controlled (confirm with trial site)
  • The surgeon plans to perform sleeve gastrectomy surgery at the same time as the study procedure
  • You have uncontrolled high blood pressure, high cholesterol, or sleep apnea
  • You have had previous surgery on your intestines, colon, or the first part of your small intestine (duodenum), other than weight-loss surgery
  • You have had previous surgery, injury, implants, or a medical condition affecting your anatomy in a way that would make the study procedure unsafe or impossible
  • You have severe acid reflux disease that cannot be controlled
  • You have a condition called Barrett's disease (a change in the lining of the food pipe)
  • You have a stomach infection caused by the bacteria Helicobacter pylori or you have active stomach ulcers
  • You have a large hiatal hernia (where part of the stomach pushes up into the chest)
  • You have inflammatory bowel disease or a colon condition called diverticulitis
  • You have any physical condition that would prevent a camera or tube from being passed through your mouth into your stomach (confirm with trial site)
  • You have any condition that would prevent keyhole (laparoscopic) or camera-guided (endoscopic) surgery (confirm with trial site)
  • You have an implanted pacemaker or defibrillator (heart devices)
  • You have a psychiatric (mental health) condition, except for depression that has been well managed with medication for more than 6 months
  • You have a history of substance abuse
  • You are pregnant, breastfeeding, or planning to become pregnant during the study; women who could become pregnant must agree to use reliable contraception
  • Your doctor or anaesthetist has concerns about your general health or fitness that make this procedure unsafe for you
  • You have unhealed ulcers, bleeding, tumours, or other tissue problems at the site where the study device would be placed
  • You are likely to need an MRI scan within the first 2 months after the procedure
  • You have had or are planning any other surgery or procedure within 30 days before or after the study procedure
  • You have had a stroke or mini-stroke (TIA) within the 6 months before signing the consent form
  • You need ongoing blood-thinning medication (other than aspirin)
  • You have an active infection requiring antibiotics that has not been resolved before the study procedure
  • You stopped using tobacco or nicotine products less than 3 months before signing the consent form
  • You have a known allergy to any components of the study device (including a material called PGLA) or to contrast dye used in imaging
  • You have a serious health condition that means you are unlikely to live for more than 12 months
  • You are currently taking part in another clinical trial of an unapproved drug or device that has not yet reached its main results stage
  • You have tested positive for COVID-19 before the study procedure, in line with local guidelines
  • You have any other medical, physical, social, or psychological condition that, in your doctor's opinion, could affect your ability to take part or complete the study (confirm

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Active, Not Recruiting
Phase
Not Applicable
Sponsor
GT Metabolic Solutions, Inc.
Registry
clinicaltrials_gov
Start date
13 August 2024
Est. completion
4 September 2025

Where this trial is recruiting

🇦🇺 Australia

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Feasibility and performance of the side-to-side anastomosis for duodeno-ileal diversion using the MagDI System.; Safety of the MagDI System

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov